Health Law Section CLE: The Corporate Transparency Act
Date: Feb 8, 2024 5:00 p.m. – 6:00 p.m.
Section Price: $29
Areas of Law: Health
- Peter S. Murphy, Esq.
- Saul Ewing, Wilmington
- Sarah Nichols
- Saul Ewing LLP, Newark
- Lisa Gora, Esq.
- Epstein Becker & Green, P.C., Newark
Beginning Jan. 1, 2024, the Corporate Transparency Act (CTA) requires certain U.S. and foreign entities defined as "reporting companies" to report certain identifying information about themselves, their beneficial owners, and company applicants to FinCEN (the U.S. Dept. of the Treasury's Financial Crimes Enforcement Network) within a certain prescribed time period.
Failure to comply with the new reporting requirements will result in civil and criminal penalties. The CTA imposes a civil penalty of not more than $500 for each day that there is a willful failure to report complete beneficial ownership information or a willful provision of or willful attempt to provide false or fraudulent beneficial ownership information. Further, a person may face a fine of up to $10,000 and imprisonment.
The CTA includes several exemptions, which may mean some larger healthcare entities will not have to meet the reporting requirements. However, smaller healthcare entities are not likely to be exempt. Therefore, they must understand and comply with the new requirements. Smaller healthcare entities are not alone. Management service organizations (MSOs) that are owned in part by private equity and some joint venture arrangements may be required to report.
Our panelists will guide healthcare counsel on the CTA and what it means for healthcare entities. The panel will provide an overview of the CTA and will discuss how the new CTA requirements apply to physician groups, physician-hospital joint ventures and other joint venture arrangements, and MSOs co-owned by private equity firms. The panel will offer best practices for meeting CTA requirements.
The panel will review these and other important considerations:
• Which healthcare entities will likely be most affected by the CTA's implementation and why?
• What exemptions may apply?
• How will the CTA's reporting requirements affect physician-hospital JVs and other transactions?
|NJ CLE information: This program has been approved by the Board on Continuing Legal Education of the Supreme Court of New Jersey for 1.2 hours of total CLE credit (Full Credits Available: NJ General: 1.2).
|NY CLE (t&nt):
|NY Professional Practice Non-Transitional: 1.0
|PA Substantive Credit: 1.0
New: No PACLE fee is required for this program. To earn PA CLE credits, a valid PA Bar ID number must be entered into the CLE form provided after attending the program.
Important Information About Our Events, Meetings, and More:
To secure your spot and receive important updates about our events, meetings, and other gatherings, such as schedule changes, remember to register in advance.
Cancellation and Refund Policy:
If you need to cancel your registration and are not transferring to another program or date, please submit a written request to us at least three business days before the event, meeting, or gathering. You will receive a refund minus a $20.00 cancellation fee. No refunds or registration changes will be issued within three business days of the event, meeting, or gathering.
Registered participants will be notified of any schedule changes. For updates regarding inclement weather, please check your email or visit NJSBA.com.
By participating in our events, meetings, or other gatherings, you agree to be photographed and/or recorded. Additionally, all media content captured during these gatherings will become the property of NJSBA. This content, including your image and name, may be used in our future promotional materials without additional consent or compensation.